Literature DB >> 8504530

Biological variability in concentrations of serum lipids: sources of variation among results from published studies and composite predicted values.

S J Smith1, G R Cooper, G L Myers, E J Sampson.   

Abstract

To obtain the best estimates of the average intraindividual biological variability (CVb) in the concentrations of total cholesterol (TC), low-density lipoprotein cholesterol (LDLC), high-density lipoprotein cholesterol (HDLC), and triglyceride serum lipids in a person's blood, we evaluated results from 30 studies published from 1970 to 1992. The usually more applicable random-effects model estimated an average CVb of 6.1% for TC, 7.4% for HDLC, 9.5% for LDLC, and 22.6% for triglyceride. Composite estimates of the average CVb from all evaluated published studies by different models of estimation ranged from 6.0% to 6.4% for TC, from 6.2% to 7.5% for HDLC, from 7.0% to 9.6% for LDLC, and from 22.4% to 22.9% for triglyceride. Two important factors influenced the reported biological variation of the study subjects: (a) the magnitude of the variability of the analytical method used and (b) the design characteristics of the study--primarily the number of subjects, the sampling interval, and the number of measurements per subject. For TC, we found a statistically significant positive correlation between the reported mean CVb and both the number of study subjects and the analytical variation. For TC and LDLC we estimate CVb as a function of the study design features. The number of patient specimens required to obtain reliable estimates for serum lipid concentrations are determined from the CVb and the current analytical variation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8504530

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  15 in total

1.  Reference change values of blood analytes from physically active subjects.

Authors:  Lázaro Alessandro S Nunes; René Brenzikofer; Denise Vaz de Macedo
Journal:  Eur J Appl Physiol       Date:  2010-05-06       Impact factor: 3.078

2.  The effects of errors in lipid measurement and assessment.

Authors:  Gerald R Cooper; Gary L Myers; Mary M Kimberly; And Parvin P Waymack
Journal:  Curr Cardiol Rep       Date:  2002-11       Impact factor: 2.931

3.  Reliability and validity of food frequency questionnaire and nutrient biomarkers in elders with and without mild cognitive impairment.

Authors:  Gene L Bowman; Jackilen Shannon; Emily Ho; Maret G Traber; Balz Frei; Barry S Oken; Jeffery A Kaye; Joseph F Quinn
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Jan-Mar       Impact factor: 2.703

4.  Analytical and biological variability in biomarker measurement in the Hispanic Community Health Study/Study of Latinos.

Authors:  Bharat Thyagarajan; Annie Green Howard; Ramon Durazo-Arvizu; John H Eckfeldt; Marc D Gellman; Ryung S Kim; Kiang Liu; Armando J Mendez; Frank J Penedo; Gregory A Talavera; Marston E Youngblood; Lihui Zhao; Daniela Sotres-Alvarez
Journal:  Clin Chim Acta       Date:  2016-10-15       Impact factor: 3.786

5.  Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment.

Authors:  Ric M Procyshyn; Kishor M Wasan; Allen E Thornton; Alasdair M Barr; Eric Y H Chen; Edith Pomarol-Clotet; Emmanuel Stip; Richard Williams; G William Macewan; C Laird Birmingham; William G Honer
Journal:  J Psychiatry Neurosci       Date:  2007-09       Impact factor: 6.186

6.  The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages.

Authors:  Margarita de la Llera-Moya; Denise Drazul-Schrader; Bela F Asztalos; Marina Cuchel; Daniel J Rader; George H Rothblat
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-01-14       Impact factor: 8.311

7.  Recommendations for lipid testing and reporting by Australian pathology laboratories.

Authors:  Charles A Appleton; Grahame Caldwell; Alan McNeil; Matthew Meerkin; Ken Sikaris; David R Sullivan; David W Thomas; David P Tognarini
Journal:  Clin Biochem Rev       Date:  2007-05

8.  The use of fasting vs. non-fasting triglyceride concentration for estimating the prevalence of high LDL-cholesterol and metabolic syndrome in population surveys.

Authors:  Jouko Sundvall; Jaana Leiviskä; Tiina Laatikainen; Markku Peltonen; Veikko Salomaa; Mauno Vanhala; Eeva Korpi-Hyövälti; Jukka Lauronen; Georg Alfthan
Journal:  BMC Med Res Methodol       Date:  2011-05-10       Impact factor: 4.615

9.  Assessing the prevalence of the Metabolic Syndrome according to NCEP ATP III in Germany: feasibility and quality aspects of a two step approach in 1550 randomly selected primary health care practices.

Authors:  Susanne Moebus; Jens Ulrich Hanisch; Markus Neuhäuser; Pamela Aidelsburger; Jürgen Wasem; Karl-Heinz Jöckel
Journal:  Ger Med Sci       Date:  2006-10-09

10.  Plant sterols: factors affecting their efficacy and safety as functional food ingredients.

Authors:  Alvin Berger; Peter J H Jones; Suhad S Abumweis
Journal:  Lipids Health Dis       Date:  2004-04-07       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.